Inspire Medical Systems, Inc. 8-K

What Happened

• On May 4, 2026, Inspire Medical Systems, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release filed as an 8-K (Exhibit 99.1).
• The company also furnished investor presentation materials being used at meetings with analysts and investors in May and June 2026 (Exhibit 99.2); the presentation is available on Inspire’s Investor Relations page: https://investors.inspiresleep.com.

Key Details

• Filing date: May 4, 2026 (Current Report on Form 8-K).
• Quarter covered: Quarter ended March 31, 2026 (Q1 2026).
• Exhibits furnished: Press release (Exhibit 99.1) and presentation slides for investor meetings (Exhibit 99.2).
• Presentation materials were provided under Regulation FD (public distribution to investors and analysts); cover page iXBRL tags are included (Exhibit 104).

Why It Matters

• This 8-K notifies investors that Inspire has released its latest quarterly results and made investor presentation materials public—both are primary sources for assessing recent revenue, earnings, guidance, and operating trends.
• Because the filing itself does not include financial figures, retail investors should review the Exhibit 99.1 press release and Exhibit 99.2 slides (or the IR website) for detailed numbers and management commentary before making investment decisions.
• The Regulation FD disclosure means the same presentation content has been broadly distributed, helping ensure fair access to the company’s updates.